Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124896572 | 12489657 | 2 | F | 201606 | 20160715 | 20160622 | 20160726 | EXP | FR-GILEAD-2016-0218471 | GILEAD | 83.00 | YR | E | F | Y | 0.00000 | 20160726 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124896572 | 12489657 | 1 | PS | ZYDELIG | IDELALISIB | 1 | Oral | UNK | Y | 205858 | TABLET | ||||||||
| 124896572 | 12489657 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124896572 | 12489657 | 1 | Chronic lymphocytic leukaemia |
| 124896572 | 12489657 | 2 | Chronic lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124896572 | 12489657 | HO |
| 124896572 | 12489657 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124896572 | 12489657 | Hyponatraemia | |
| 124896572 | 12489657 | Interstitial lung disease | |
| 124896572 | 12489657 | Neutropenia | |
| 124896572 | 12489657 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124896572 | 12489657 | 1 | 201506 | 201606 | 0 | |
| 124896572 | 12489657 | 2 | 2015 | 0 |